Open Access
1056- https://doi.org/10.1021/acsnano.0c02439
Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection.
Translate Article 
The ongoing outbreak of the novel coronavirus disease (COVID-19) has spread globally and poses a threat to public health in more than 200 countries. Reliable laboratory diagnosis of the disease has been one of the foremost priorities for promoting public health interventions. The routinely used reverse transcription polymerase chain reaction (RT-PCR) is currently the reference method for COVID-19 diagnosis. However, it also reported a number of false-positive or -negative cases, especially in the early stages of the novel virus outbreak. In this work, a dual-functional plasmonic biosensor combining the plasmonic photothermal (PPT) effect and localized surface plasmon resonance (LSPR) sensing transduction provides an alternative and promising solution for the clinical COVID-19 diagnosis. The two-dimensional gold nanoislands (AuNIs) functionalized with complementary DNA receptors can perform a sensitive detection of the selected sequences from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through nucleic acid hybridization. For better sensing performance, the thermoplasmonic heat is generated on the same AuNIs chip when illuminated at their plasmonic resonance frequency. The localized PPT heat is capable to elevate the in situ hybridization temperature and facilitate the accurate discrimination of two similar gene sequences. Our dual-functional LSPR biosensor exhibits a high sensitivity toward the selected SARS-CoV-2 sequences with a lower detection limit down to the concentration of 0.22 pM and allows precise detection of the specific target in a multigene mixture. This study gains insight into the thermoplasmonic enhancement and its applicability in the nucleic acid tests and viral disease diagnosis.
- Research Article
- 22
- 10.31635/ccschem.020.202000322
- Jul 10, 2020
- CCS Chemistry
Coronavirus disease 2019 (COVID-19) is caused by a novel strain of coronavirus, designated as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has caused a global pandemic rapidly s...
- Research Article
- 54
- 10.1053/j.gastro.2020.07.043
- Jul 28, 2020
- Gastroenterology
AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy
- Research Article
- 37
- 10.1111/ajt.16082
- Jul 5, 2020
- American Journal of Transplantation
Strategies for liver transplantation during the SARS-CoV-2 outbreak: Preliminary experience from a single center in France.
- Research Article
- 5
- 10.1097/mcp.0000000000000771
- Mar 1, 2021
- Current Opinion in Pulmonary Medicine
Editorial: Coronavirus disease 2019 (COVID-19) - advances in epidemiology, diagnostics, treatments, host-directed therapies, pathogenesis, vaccines, and ongoing challenges.
- Research Article
- 7
- 10.1038/s41436-021-01113-0
- Jun 1, 2021
- Genetics in Medicine
The intersection of genetics and COVID-19 in 2021: preview of the 2021 Rodney Howell Symposium
- Discussion
- 25
- 10.1002/uog.24809
- Jan 13, 2022
- Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
Does COVID-19 cause pre-eclampsia?
- Research Article
- 23
- 10.12968/hmed.2020.0156
- Apr 2, 2020
- British Journal of Hospital Medicine
Discontinuation of antiviral drugs may be the reason for recovered COVID-19 patients testing positive again.
- Research Article
- 13
- 10.1111/ajt.16572
- Apr 2, 2021
- American Journal of Transplantation
Multisystem inflammatory syndrome in children associated with SARS-CoV-2 in a solid organ transplant recipient.
- Discussion
- 1
- 10.1016/j.jinf.2021.11.008
- Nov 14, 2021
- Journal of Infection
Persistence of anti-SARS-CoV-2 IgM in convalescent COVID-19 patients
- Discussion
- 1
- 10.1053/j.jvca.2020.08.041
- Aug 26, 2020
- Journal of Cardiothoracic and Vascular Anesthesia
Testing the Asymptomatic Pre-Surgical Population for Severe Acute Respiratory Syndrome Coronavirus 2
- Research Article
- 23
- 10.1097/cm9.0000000000000899
- Jul 5, 2020
- Chinese Medical Journal
In December 2019, a novel coronavirus was identified in Wuhan City, Hubei Province, China and later the disease was named coronavirus disease 2019 (COVID-19). On March 11, 2020, the World Health Organization (WHO) officially announced that COVID-19 had reached global pandemic status. This article summarized the understanding of the etiology, pathogenesis, epidemiology, clinical characteristics, diagnosis, treatment, rehabilitation, and prevention and control measures of COVID-19 based on the available data and anti-epidemic experience in China.
- Discussion
- 22
- 10.1016/j.jinf.2020.10.007
- Oct 8, 2020
- The Journal of Infection
False negative RT-PCR and false positive antibody tests–Concern and solutions in the diagnosis of COVID-19
- Research Article
- 1
- 10.25303/1610rjbt163170
- Sep 25, 2021
- Research Journal of Biotechnology
Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is a novel coronavirus. There is a constant increase in number of positive cases for COVID-19. The objective of this review is to study technology tools and sensors available for detection and diagnosis of COVID-19. COVID -19 pandamic has created surge demand for essential health care instrumentation, medicines along with technology and tools for proper control and management of corona virus. Diagnosing and screening of COVID-19 is possible using nucleic acid testing and CT scans. In this study, we have described Field-effect transistorbased graphene sensor and Plasmonic Photothermal(PPT) biosensor for highly accurate SARS-CoV-2 detection. A dual-functional localized surface plasmon resonance (LSPR) biosensor combining the photothermal effect and plasmonic sensing transduction is used for SARS-CoV-2 viral nucleic acid detection. FET based sensor for COVID- 19 used a graphene channel coupled to the SARS-CoV- 2 spike antibody with the efficient gating effect of the FET through phosphate -buffered saline (PBS; pH 7.4) buffer as the electrolyte covering. The aqueous solution-gated FET system detects SARS-CoV-2 based on electrical signal due to changes in channel surface potential. Industry 4.0 technologies such as Artificial Intelligence (AI), Internet of things(IOT) have helped in early detection and diagnosis. AI can build an intellegent platform with neural network for automatic monitoring and prediction of the spread of virus.IOT can assist in diagnosis and treatment of COVID-19 patients and can help in setting in advanced clinical work. Industry 4.0 technologies improve the working efficiency of the health care professional and provide better solution.
- Discussion
- 63
- 10.1016/j.jpeds.2020.06.057
- Jun 22, 2020
- The Journal of Pediatrics
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Two Different Illnesses with Overlapping Clinical Features
- Research Article
- 66
- 10.1111/ajt.16133
- Jul 4, 2020
- American Journal of Transplantation
Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation.
Save Important notes in documents
Highlight text to save as a note, or write notes directly
You can also access these Documents in Paperpal, our AI writing tool
Powered by our AI Writing Assistant
